Characterization of CYP26B1-selective inhibitor, DX314, as a potential therapeutic for keratinization disorders

Joachim Veit, VALERIE DE GLAS, Benoit Balau, Haoming Liu, Florence Bourlond, Amy Paller, Yves Poumay, Philippe Diaz

Research output: Contribution to journalArticlepeer-review

112 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Characterization of CYP26B1-selective inhibitor, DX314, as a potential therapeutic for keratinization disorders'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science